144 related articles for article (PubMed ID: 31687171)
1. Impact of anti-obesity medication initiation and duration on weight loss in a comprehensive weight loss programme.
Safavi R; Lih A; Kirkpatrick S; Haller S; Bailony MR
Obes Sci Pract; 2019 Oct; 5(5):468-478. PubMed ID: 31687171
[TBL] [Abstract][Full Text] [Related]
2. Real World Use of Anti-Obesity Medications and Weight Change in Veterans.
Hung A; Wong ES; Dennis PA; Stechuchak KM; Blalock DV; Smith VA; Hoerster K; Vimalananda VG; Raffa SD; Maciejewski ML
J Gen Intern Med; 2024 Mar; 39(4):519-528. PubMed ID: 37962730
[TBL] [Abstract][Full Text] [Related]
3. The association between previous use of anti-obesity medication and semaglutide weight loss outcomes.
Ghusn W; Fansa S; Anazco D; Tama E; Cifuentes L; Gala K; De La Rosa A; Sacoto D; Campos A; Feris F; Hurtado D; Acosta A
Diabetes Obes Metab; 2024 Jun; 26(6):2167-2175. PubMed ID: 38469598
[TBL] [Abstract][Full Text] [Related]
4. Economic outcomes of antiobesity medication use among adults in the United States: A retrospective cohort study.
Watkins S; Toliver JC; Kim N; Whitmire S; Garvey WT
J Manag Care Spec Pharm; 2022 Oct; 28(10):1066-1079. PubMed ID: 35856489
[No Abstract] [Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Determinants of successful weight loss after using a commercial web-based weight reduction program for six months: cohort study.
Postrach E; Aspalter R; Elbelt U; Koller M; Longin R; Schulzke JD; Valentini L
J Med Internet Res; 2013 Oct; 15(10):e219. PubMed ID: 24126250
[TBL] [Abstract][Full Text] [Related]
7. A comparison between weight loss outcomes with anti-obesity medications before and during Covid-19 pandemic at a tertiary weight management center.
De la Rosa A; Ghusn W; Sacoto D; Campos A; Cifuentes L; Feris F; Busebee B; Calderon G; Acosta A; Hurtado MD
Obes Pillars; 2022 Dec; 4():100046. PubMed ID: 37990666
[TBL] [Abstract][Full Text] [Related]
8. Weight regain after total meal replacement very low-calorie diet program with and with-out anti-obesity medications.
Cifuentes L; Galbiati F; Mahmud H; Rometo D
Obes Sci Pract; 2024 Feb; 10(1):e722. PubMed ID: 38263986
[TBL] [Abstract][Full Text] [Related]
9. Antiobesity Medication Use Among Overweight and Obese Adults in the United States: 2015-2018.
MacEwan J; Kan H; Chiu K; Poon JL; Shinde S; Ahmad NN
Endocr Pract; 2021 Nov; 27(11):1139-1148. PubMed ID: 34265455
[TBL] [Abstract][Full Text] [Related]
10. The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.
Spencer L; Rollo M; Hauck Y; MacDonald-Wicks L; Wood L; Hutchesson M; Giglia R; Smith R; Collins C
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):88-98. PubMed ID: 26447010
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Combining Antiobesity Medication With an Employer-Based Weight Management Program for Treatment of Obesity: A Randomized Clinical Trial.
Pantalone KM; Smolarz BG; Ramasamy A; Baz Hecht M; Harty BJ; Rogen B; Griebeler ML; Borukh E; Young JB; Burguera B
JAMA Netw Open; 2021 Jul; 4(7):e2116595. PubMed ID: 34255049
[TBL] [Abstract][Full Text] [Related]
12. Fracture rate associated with quality metric-based anti-osteoporosis treatment in glucocorticoid-induced osteoporosis.
Overman RA; Gourlay ML; Deal CL; Farley JF; Brookhart MA; Layton JB
Osteoporos Int; 2015 May; 26(5):1515-24. PubMed ID: 25600474
[TBL] [Abstract][Full Text] [Related]
13. Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study.
Finer N; Bloom SR; Frost GS; Banks LM; Griffiths J
Diabetes Obes Metab; 2000 Apr; 2(2):105-12. PubMed ID: 11220522
[TBL] [Abstract][Full Text] [Related]
14. A Randomized, Open-Label, Multiple-Dose, Parallel-Arm, Pivotal Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Aripiprazole 2-Month Long-Acting Injectable in Adults With Schizophrenia or Bipolar I Disorder.
Harlin M; Yildirim M; Such P; Madera-McDonough J; Jan M; Jin N; Watkin S; Larsen F
CNS Drugs; 2023 Apr; 37(4):337-350. PubMed ID: 36961650
[TBL] [Abstract][Full Text] [Related]
15. Weight Reduction Through a Digital Nutrition and Food Purchasing Platform Among Users With Obesity: Longitudinal Study.
Hu EA; Nguyen V; Langheier J; Shurney D
J Med Internet Res; 2020 Sep; 22(9):e19634. PubMed ID: 32792332
[TBL] [Abstract][Full Text] [Related]
16. The effects of early initiation of aripiprazole once-monthly on healthcare resource utilization and healthcare costs in individuals with schizophrenia: real-world evidence from US claims data.
Waters HC; Stellhorn R; Touya M; Fitzgerald H; Bhattacharjee S; Citrome L
J Med Econ; 2023; 26(1):316-325. PubMed ID: 36780296
[TBL] [Abstract][Full Text] [Related]
17. Tackling obesity in areas of high social deprivation: clinical effectiveness and cost-effectiveness of a task-based weight management group programme - a randomised controlled trial and economic evaluation.
McRobbie H; Hajek P; Peerbux S; Kahan BC; Eldridge S; Trépel D; Parrott S; Griffiths C; Snuggs S; Myers Smith K
Health Technol Assess; 2016 Oct; 20(79):1-150. PubMed ID: 27802843
[TBL] [Abstract][Full Text] [Related]
18. Weight loss experiences and willingness to intervention with pharmacotherapy among obese and very obese Danish people.
Jain P; Røstbjerg AS; Haase CL; Rhee NA
Phys Sportsmed; 2016 Sep; 44(3):201-7. PubMed ID: 27254773
[TBL] [Abstract][Full Text] [Related]
19. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial.
Wadden TA; Bailey TS; Billings LK; Davies M; Frias JP; Koroleva A; Lingvay I; O'Neil PM; Rubino DM; Skovgaard D; Wallenstein SOR; Garvey WT;
JAMA; 2021 Apr; 325(14):1403-1413. PubMed ID: 33625476
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
